Reuters logo
4 个月前
BRIEF-Gtx Inc qtrly loss per share $0.44
2017年3月15日 / 上午11点28分 / 4 个月前

BRIEF-Gtx Inc qtrly loss per share $0.44

1 分钟阅读

March 15 (Reuters) - Gtx Inc

* Gtx provides corporate update and reports fourth quarter and year-end 2016 financial results

* Gtx inc -expects to report preliminary results from its phase 2 clinical trial of enobosarm to treat stress urinary incontinence (sui) in q3 of 2017

* Gtx -xpects to begin an initial clinical study of selective androgen receptor degrader in men with castration-resistant prostate cancer in second half of 2017

* Gtx inc- as of december 31, 2016, cash and short-term investments were $21.9 million compared to $29.3 million at december 31, 2015

* Gtx inc qtrly loss per share $0.44 Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below